HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies SEATTLE (Wednesday, January 18, 2023) – A Phase 3 study of an investigational HIV vaccine regimen has been discontinued following a planned, interim review by the study’s independent Data and Safety Monitoring Board (DSMB) on Jan. 12, 2023. The Mosaico study – also…
DetailsWEDNESDAY 18 JANUARY 2022. CAPE TOWN, SOUTH AFRICA: We, representing the LGTBQI+ civil society and allies in Cape Town, strongly condemn the physical assault and injustice committed against Thabiso Motaung, a 19-year-old transgender woman, in Khayelitsha. What occurred was a hate crime and is a violation of her basic human rights. We call for the…
DetailsToo few South Africans living with HIV achieve viral suppression. Although advances in antiretroviral therapy (ART) have reduced illness and death for people with HIV (PWH), ongoing evidence show gaps in the HIV continuum, including poor tablet taking / adherence and low retention in care, particularly in the first 4 months after ART is started.…
Details*This article is based off a press release distributed by DTHF partner, Africa REACH. The Medicines Control Authority of Zimbabwe recently approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention, making Zimbabwe the first African country to authorize the once-every-two-months injectable PrEP drug. Zimbabwe has a PrEP program…
DetailsPeople whose sexual orientation and gender identity (SOGI) do not conform to the majority may experience hostility and exclusion in everyday life. Sexual orientation and gender identity are two separate but distinct part of people’s overall identity. Learning about these concepts for the first time can be confusing and overwhelming. Enter the SOGI Universe! The…
DetailsThe DTHF is excited to host a webinar series on adolescent health research, in partnership with IAVI. The first series ran for six months in 2021, with a monthly edition. We covered topics like the HIV & COVID-19 Intersection, Mental Health & Wellbeing, and Gender & Sexually Diverse Populations. Our second series started with a…
DetailsAre you a man or a transgender person who has sex with men? We want to talk to you! Globally HIV transmission is still a serious health issue that needs a lot of attention from governments, health care providers, and our communities. There are general services, educational campaigns and programmes for all members of…
DetailsThe Desmond Tutu Health Foundation (DTHF) would like to add our voice to the growing number of organisations that have raised concern regarding the erroneous statements made by former President Thabo Mbeki on the human immunodeficiency virus (HIV) and the cause of Acquired immunodeficiency syndrome (AIDS). In the era that has become known as a…
DetailsUNAIDS goals specify that country programs should achieve viral suppression in at least 90% of those who start antiretroviral treatment (ART). In South Africa, only 51-68% of those on antiretroviral treatment (ART) achieve viral suppression, both through poor adherence and loss to care. The greatest losses occur in the first year on ART, with the…
Details
